癌におけるビタミンB6経路の多面的な役割:代謝,免疫相互作用,時間的および空間的調節
Sushanta Kumar Mishra1, Bo Li1, Ana S H Costa2
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.
Genes & development
|August 22, 2025
まとめ
ビタミンB6は代謝経路に不可欠で 栄養失調が癌を引き起こす ビタミンB6の代謝をターゲットにすることで 腫瘍に対する新たな治療戦略が生まれます
科学分野:
- 生物化学
- 腫瘍学
- 代謝経路
背景:
- ビタミンB6は,重要な調節経路における重要な代謝コファクターとして作用する.
- ビタミンB6の欠乏や不調は様々ながんの腫瘍性プログラムと関連している.
研究 の 目的:
- 腫瘍形成におけるビタミンB6の多面的な役割に関するメカニズム的洞察をレビューする.
- ビタミンB6の代謝を癌治療の標的として検討する.
主な方法:
- 癌におけるビタミンB6に関するメカニズム学的研究の文献レビュー.
- ビタミンB6に関連する腫瘍特有の代謝動態と脆弱性の分析
- ビタミンB6の腫瘍発生過程への影響に関する現在の理解をまとめます.
主要な成果:
- ビタミンB6の欠乏/不調は重要な代謝経路を混乱させ,癌の発生を促します.
- ビタミンB6に依存するプロセスは,がん細胞の増殖,シグナル伝達,免疫反応,代謝再プログラムに影響します.
- 腫瘍特有のビタミンB6代謝は,文脈に依存する脆弱性を明らかにする.
結論:
- ビタミンB6は癌に複雑な役割を果たし,複数の腫瘍発生過程に影響を与えます.
- ダイナミックなビタミンB6代謝をターゲットにすることで 新しい腫瘍特異的介入の 治療方法が期待されます
関連する概念動画
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


